IA Trial Radar | ||
|---|---|---|
O estudo clínico NCT04425421 (GFALMB2019) para Linfoma de Burkitt está recrutando. Consulte a visualização em cartões do Radar de Estudos Clínicos e as ferramentas de descoberta de IA para ver todos os detalhes. Ou pergunte qualquer coisa aqui. | ||
Um estudo correspondeu aos critérios de filtro (abaixo)
Visualização em cartões
Recommendations for the Treatment of Children With Burkitt's Lymphoma (GFALMB2019)
Os detalhes do estudo clínico estão disponíveis principalmente em inglês. No entanto, a IA Trial Radar pode ajudar! Basta clicar em 'Explicar o estudo' para visualizar e discutir as informações do estudo no idioma selecionado.
O estudo clínico NCT04425421 (GFALMB2019) é um ensaio observacional para Linfoma de Burkitt. Seu status atual é: recrutando. O estudo começou em 1 de novembro de 2020 e pretende incluir 1.000 participantes. Coordenado por French Africa Pediatric Oncology Group e deve ser concluído em 31 de dezembro de 2028. Essas informações foram atualizadas no ClinicalTrials.gov em 3 de outubro de 2025.
Resumo
This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.
Descrição detalhada
This is the 4th Burkitt's Lymphoma (LMB) study by the GFAOP group. This study hopes to include at least 14 Sub Saharian countries some of whom have never participated in a LMB study. The evaluation of improvement in early diagnosis should be possible in this study. The study hopes to be able to evaluate children earlier, with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for children with a stage IV disease.
Título oficial
Recommendations for the Treatment of Children With Burkitt's Lymphoma
Condições
Linfoma de BurkittOutros IDs do estudo
- GFALMB2019
- GFA LMB 2019
Número NCT
Data de início (real)
2020-11-01
Última atualização postada
2025-10-03
Data de conclusão (estimada)
2028-12-31
Inscrição (estimada)
1.000
Tipo de estudo
Observacional
Status
Recrutando
Braços / Intervenções
| Grupo de participantes/Braço | Intervenção/Tratamento |
|---|---|
N/A | OBSERVACIONAL OBSERVAITON OF THE CAPACITY OF THE GROUP TO TREAT ACCORDING TO THE PROTOCOLE AND LOOK AT OUTCOME FOR STAGE I AND II DISEASE |
Desfecho primário
Desfecho secundário
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Evaluation of the number of cases with local disease. | evaluating the initial clinical reports and later histological reports to confirm the diagnosis and the stage. | 5 years |
Evaluation of the number of cases by stage at the time of diagnosis. | evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis. | 5 Years |
Evaluating the treatment given. | Comparison of treatment given and recommended treatment. | 5 Years |
Evaluating the follow up after treatment. | How many children alive or dead after treatment | 5 Years |
Number of relapse cases | The evaluation and the treatment of relapse and outcome | 5 years |
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Application of therapeutic recommendations | Evaluations of the correct application of recommendations | 5 years |
Critérios de elegibilidade
Idades elegíveis
Criança, Adulto
Sexos elegíveis
Todos
Clinical diagnosis of Burkitt's Lymphoma: all location. Diagnosis by cytology or histology. Not possible to follow all the treatment.
-
Not a B Cell tumor. Child has been previously treated. Child has also another illness which would render the treatment incompatible. Parents refusal.
French Africa Pediatric Oncology GroupContato central do estudo
Contato: Chantal Ms BOUDA, Dr., 00(226)70 10 01 30, [email protected]
Contato: BRENDA MALLON, MSc, 0033142115411, [email protected]
7 Locais do estudo em 6 países
Hopital Yalgado Ouedraogo, Ouagadougou, 03 BP 7022, Burkina Faso
BOUDA CHANTAL, DR, Contato
Recrutando
CHU de Treichville à ABIDJAN, Abidjan, Côte d’Ivoire
Line Dr COUITCHERE, MD, Contato, [email protected]
Recrutando
Kinshasa City
Cliniques Universitaires de Kinshasa, Kinshasa, Kinshasa City, BP 12 KIN XI, Democratic Republic of the Congo
BUDIONGO Aléine, DR, Contato
Recrutando
Cliniques Universitaires de Lubumbashi (CUL), Lubumbashi, BP 1825, Democratic Republic of the Congo
LUKAMBA Robert, DR, Contato, 00(243) 814024633, [email protected]
Recrutando
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona, Antananarivo, BP 4150, Madagascar
Mbolanirina RAKOTOMAHEFA, Dr, Contato, 34 14 201 51
Recrutando
CHU Gabriel Touré (HGT), Bamako, Mali
BOUBACAR TOGO, PROFESSEUR, Contato, +223 66 74 29 04, [email protected]
Recrutando
Hôpital Aristide Le Dantec, Dakar, BP 3001, Senegal
Fatou-Binetou DIAGNE AKONDE, Dr, Contato, 00(221)77 637 40 63
Recrutando